Bohnen Shane has filed 19 insider transactions across 1 company since April 2024.
Most recent transaction: a option exercise of 1718 shares of BIO-TECHNE Corp ($TECH) on August 15, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | M | Common Stock | 1718 | $0.00 | 4,912.0000 | 159,717,000 | 53.79% | 0.00% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | F | Common Stock | 527 | $53.60 | 4,385.0000 | 159,717,000 | 10.73% | 0.00% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | M | Restricted Stock Units | 50 | $0.00 | 2,308.0000 | 159,717,000 | 2.12% | 0.00% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | M | Restricted Stock Units | 1668 | $0.00 | 5,597.0000 | 159,717,000 | 22.96% | 0.00% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | A | Performance Restricted Stock Units | 13992 | $0.00 | 28,806.0000 | 159,717,000 | 94.45% | 0.01% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | A | Restricted Stock Units | 6996 | $0.00 | 9,255.0000 | 159,717,000 | 309.69% | 0.00% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | A | Stock Option (Right to Buy) | 17897 | $0.00 | 76,375.0000 | 159,717,000 | 30.60% | 0.01% |
| April 3, 2025 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | M | Common Stock | 2260 | $0.00 | 3,941.0000 | 158,944,000 | 134.44% | 0.00% |
| April 3, 2025 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | F | Common Stock | 747 | $54.86 | 3,194.0000 | 158,944,000 | 18.95% | 0.00% |
| April 3, 2025 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | M | Restricted Stock Units | 2260 | $0.00 | 7,364.0000 | 158,944,000 | 23.48% | 0.00% |
| Aug. 15, 2024 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | M | Common Stock | 49 | $0.00 | 1,696.0000 | 160,774,000 | 2.98% | 0.00% |
| Aug. 15, 2024 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | F | Common Stock | 15 | $74.91 | 1,681.0000 | 160,774,000 | 0.88% | 0.00% |
| Aug. 15, 2024 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | M | Restricted Stock Units | 49 | $0.00 | 4,618.0000 | 160,774,000 | 1.05% | 0.00% |
| Aug. 15, 2024 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | A | Performance Restricted Stock Units | 10012 | $0.00 | 14,814.0000 | 160,774,000 | 208.50% | 0.01% |
| Aug. 15, 2024 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | A | Restricted Stock Units | 5006 | $0.00 | 9,525.0000 | 160,774,000 | 110.78% | 0.00% |
| Aug. 15, 2024 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | A | Stock Option (Right to Buy) | 13488 | $0.00 | 58,478.0000 | 160,774,000 | 29.98% | 0.01% |
| April 3, 2024 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | M | Common Stock | 2259 | $0.00 | 2,394.0000 | 160,496,000 | 1673.33% | 0.00% |
| April 3, 2024 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | F | Common Stock | 747 | $67.87 | 1,647.0000 | 160,496,000 | 31.20% | 0.00% |
| April 3, 2024 | BIO-TECHNE Corp | $TECH | Bohnen Shane | SVP - General Counsel | M | Restricted Stock Units | 2259 | $0.00 | 4,519.0000 | 160,496,000 | 33.33% | 0.00% |